Amarin Corp Plc (AMRN)

[HDGabor]

J- (&L0tsaluck2000)

I also strongly disagree that biotech valuation/acquisition decision criteria are the same as any other industry … valuations and buy criteria absolutely differ by industry, and even from deal to deal.

Could you give some example? What is the difference(s)? What is sector specific?

To avoid any doubt: I did not say that all pieces / details are exactly the same but the general process / method is. Of course the basis / method is different between developing and established companies but it is not sector related.

Best,
G
ps.:

L0tsaluck2000

Mr Gabor brings some valuable business experience and perspective to the board it's just he fails to realize he is not alone in experience or perspective.

IIRC I did not question the experience of anybody (till he / she prove it "otherwise"). Definitely not in an area the isn't mine.